TALPHERA, INC. Payments to Acquire Investments
TALPHERA, INC. (TLPH) reported Payments to Acquire Investments of $17.82 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-03-23
- TALPHERA, INC. payments to acquire investments for the quarter ending 2025-12-31 was $0.00.
- TALPHERA, INC. payments to acquire investments for the quarter ending 2025-09-30 was $17.82M.
- TALPHERA, INC. payments to acquire investments for the quarter ending 2024-12-31 was $0.00.
- TALPHERA, INC. payments to acquire investments for the quarter ending 2024-09-30 was $0.00.
- TALPHERA, INC. payments to acquire investments for fiscal 2025 was $17.82M, a 257.80% increase from fiscal 2024.
- TALPHERA, INC. payments to acquire investments for fiscal 2024 was $4.98M.
- TALPHERA, INC. payments to acquire investments for fiscal 2020 was $44.61M, a 55.42% decline from fiscal 2019.
- TALPHERA, INC. payments to acquire investments for fiscal 2019 was $100.07M, a 227.47% increase from fiscal 2018.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month | Payments to Acquire Investments 72 month | Payments to Acquire Investments 75 month | Payments to Acquire Investments 78 month | Payments to Acquire Investments 81 month | Payments to Acquire Investments 84 month | Payments to Acquire Investments 87 month | Payments to Acquire Investments 90 month | Payments to Acquire Investments 93 month | Payments to Acquire Investments 96 month | Payments to Acquire Investments 99 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $17.82M derived: sum of 2 quarters · filed 2026-03-23 | $17.82M 10-K · filed 2026-03-23 | |||||||||||
| 2025-09-30 | $17.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $17.82M 10-Q · filed 2025-11-12 | ||||||||||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | |||||||||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $0.00 derived: sum of 2 quarters · filed 2026-03-23 | $4.98M 10-K · filed 2026-03-23 | |||||||||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.98M 10-Q · filed 2025-11-12 | ||||||||||||
| 2024-06-30 | $4.98M 10-Q · filed 2025-08-14 | |||||||||||||
| 2021-09-30 | $15.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $29.43M derived: sum of 2 quarters · filed 2021-11-15 | $53.87M 10-Q · filed 2021-11-15 | $59.66M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||
| 2021-06-30 | $13.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $38.20M 10-Q · filed 2021-08-16 | $43.99M derived: sum of 3 quarters · filed 2021-08-16 | $54.01M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||
| 2021-03-31 | $24.44M 10-Q · filed 2021-05-17 | $30.23M derived: sum of 2 quarters · filed 2021-05-17 | $40.24M derived: sum of 3 quarters · filed 2021-11-15 | $56.30M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||
| 2020-12-31 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $15.80M derived: sum of 2 quarters · filed 2021-11-15 | $31.85M derived: sum of 3 quarters · filed 2021-11-15 | $44.61M 10-K · filed 2021-03-15 | ||||||||||
| 2020-09-30 | $10.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $26.06M derived: sum of 2 quarters · filed 2021-11-15 | $38.82M 10-Q · filed 2021-11-15 | $56.96M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||
| 2020-06-30 | $16.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $28.81M 10-Q · filed 2021-08-16 | $46.95M derived: sum of 3 quarters · filed 2021-08-16 | $100.72M derived: sum of 4 quarters · filed 2021-08-16 | ||||||||||
| 2020-03-31 | $12.76M 10-Q · filed 2021-05-17 | $30.90M derived: sum of 2 quarters · filed 2021-05-17 | $84.67M derived: sum of 3 quarters · filed 2021-05-17 | $108.95M derived: sum of 4 quarters · filed 2021-05-17 | ||||||||||
| 2019-12-31 | $18.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $71.91M derived: sum of 2 quarters · filed 2021-03-15 | $96.20M derived: sum of 3 quarters · filed 2021-03-15 | $100.07M 10-K · filed 2021-03-15 | ||||||||||
| 2019-09-30 | $53.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $78.05M derived: sum of 2 quarters · filed 2020-11-05 | $81.92M 10-Q · filed 2020-11-05 | $99.64M derived: sum of 4 quarters · filed 2021-03-15 | ||||||||||
| 2019-06-30 | $24.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $28.16M 10-Q · filed 2020-08-10 | $45.87M derived: sum of 3 quarters · filed 2021-03-15 | $45.87M derived: sum of 4 quarters · filed 2021-03-15 | ||||||||||
| 2019-03-31 | $3.87M 10-Q · filed 2020-05-11 | $21.59M derived: sum of 2 quarters · filed 2021-03-15 | $21.59M derived: sum of 3 quarters · filed 2021-03-15 | $33.43M derived: sum of 4 quarters · filed 2021-03-15 | ||||||||||
| 2018-12-31 | $17.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $17.71M derived: sum of 2 quarters · filed 2021-03-15 | $29.56M derived: sum of 3 quarters · filed 2021-03-15 | $30.56M 10-K · filed 2021-03-15 | ||||||||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $11.85M derived: sum of 2 quarters · filed 2019-11-07 | $12.84M 10-Q · filed 2019-11-07 | |||||||||||
| 2018-06-30 | $11.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $12.84M 10-Q · filed 2019-08-06 | ||||||||||||
| 2018-03-31 | $995.00K 10-Q · filed 2019-05-09 | |||||||||||||
| 2017-12-31 | $7.57M 10-K · filed 2020-03-16 | |||||||||||||
| 2016-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $3.00K derived: sum of 2 quarters · filed 2019-03-07 | $996.00K 10-K · filed 2019-03-07 | |||||||||||
| 2016-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $998.00K 10-Q · filed 2017-11-09 | ||||||||||||
| 2016-06-30 | $993.00K 10-Q · filed 2017-08-02 | |||||||||||||
| 2015-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $1.72M derived: sum of 2 quarters · filed 2018-03-09 | $4.80M derived: sum of 3 quarters · filed 2018-03-09 | $7.27M 10-K · filed 2018-03-09 | ||||||||||
| 2015-09-30 | $1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $4.80M derived: sum of 2 quarters · filed 2016-11-02 | $7.26M 10-Q · filed 2016-11-02 | $9.81M derived: sum of 4 quarters · filed 2017-03-03 | ||||||||||
| 2015-06-30 | $3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $5.54M 10-Q · filed 2016-07-29 | $8.09M derived: sum of 3 quarters · filed 2017-03-03 | $18.09M derived: sum of 4 quarters · filed 2017-03-03 | ||||||||||
| 2015-03-31 | $2.47M 10-Q · filed 2016-05-02 | $5.01M derived: sum of 2 quarters · filed 2017-03-03 | $15.02M derived: sum of 3 quarters · filed 2017-03-03 | $18.54M derived: sum of 4 quarters · filed 2017-03-03 | ||||||||||
| 2014-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $12.55M derived: sum of 2 quarters · filed 2017-03-03 | $16.07M derived: sum of 3 quarters · filed 2017-03-03 | $17.43M 10-K · filed 2017-03-03 | ||||||||||
| 2014-09-30 | $10.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $13.53M derived: sum of 2 quarters · filed 2015-11-03 | $14.88M 10-Q · filed 2015-11-03 | $17.19M derived: sum of 4 quarters · filed 2016-03-07 | ||||||||||
| 2014-06-30 | $3.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $4.88M 10-Q · filed 2015-08-04 | $7.18M derived: sum of 3 quarters · filed 2016-03-07 | $14.87M derived: sum of 4 quarters · filed 2016-03-07 | ||||||||||
| 2014-03-31 | $1.36M 10-Q · filed 2015-05-05 | $3.66M derived: sum of 2 quarters · filed 2016-03-07 | $11.35M derived: sum of 3 quarters · filed 2016-03-07 | $21.00M derived: sum of 4 quarters · filed 2016-03-07 | ||||||||||
| 2013-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-07 | $9.99M derived: sum of 2 quarters · filed 2016-03-07 | $19.64M derived: sum of 3 quarters · filed 2016-03-07 | $28.01M 10-K · filed 2016-03-07 | ||||||||||
| 2013-09-30 | $7.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $17.34M derived: sum of 2 quarters · filed 2014-11-10 | $25.70M 10-Q · filed 2014-11-10 | $29.34M derived: sum of 4 quarters · filed 2015-03-13 | $137.54M 10-Q · filed 2013-11-05 | |||||||||
| 2013-06-30 | $9.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $18.02M 10-Q · filed 2014-08-11 | $21.66M derived: sum of 3 quarters · filed 2015-03-13 | $25.11M derived: sum of 4 quarters · filed 2015-03-13 | $129.86M 10-Q · filed 2013-08-12 | |||||||||
| 2013-03-31 | $8.37M 10-Q · filed 2014-05-08 | $12.00M derived: sum of 2 quarters · filed 2015-03-13 | $15.45M derived: sum of 3 quarters · filed 2015-03-13 | $25.09M derived: sum of 4 quarters · filed 2015-03-13 | $120.20M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $7.08M derived: sum of 2 quarters · filed 2015-03-13 | $16.73M derived: sum of 3 quarters · filed 2015-03-13 | $27.17M 10-K · filed 2015-03-13 | $111.83M 10-K · filed 2013-03-12 | |||||||||
| 2012-09-30 | $3.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $13.09M derived: sum of 2 quarters · filed 2013-11-05 | $23.53M 10-Q · filed 2013-11-05 | $29.61M derived: sum of 4 quarters · filed 2014-03-17 | $108.19M 10-Q · filed 2012-11-06 | |||||||||
| 2012-06-30 | $9.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $20.08M 10-Q · filed 2013-08-12 | $26.17M derived: sum of 3 quarters · filed 2014-03-17 | $39.64M derived: sum of 4 quarters · filed 2014-03-17 | $104.75M 10-Q · filed 2012-08-10 | |||||||||
| 2012-03-31 | $10.44M 10-Q · filed 2013-05-08 | $16.53M derived: sum of 2 quarters · filed 2014-03-17 | $30.00M derived: sum of 3 quarters · filed 2014-03-17 | $46.77M derived: sum of 4 quarters · filed 2014-03-17 | $95.11M 10-Q · filed 2012-05-09 | |||||||||
| 2011-12-31 | $6.09M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $19.56M derived: sum of 2 quarters · filed 2014-03-17 | $36.33M derived: sum of 3 quarters · filed 2014-03-17 | $39.37M 10-K · filed 2014-03-17 | $84.67M 10-K · filed 2012-03-23 | |||||||||
| 2011-09-30 | $13.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $30.24M derived: sum of 2 quarters · filed 2012-11-06 | $33.28M 10-Q · filed 2012-11-06 | $33.38M derived: sum of 4 quarters · filed 2013-03-12 | $78.58M 10-Q · filed 2011-11-08 | |||||||||
| 2011-06-30 | $16.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $19.81M 10-Q · filed 2012-08-10 | $19.91M derived: sum of 3 quarters · filed 2013-03-12 | $24.25M derived: sum of 4 quarters · filed 2013-03-12 | $65.11M 10-Q · filed 2011-08-11 | |||||||||
| 2011-03-31 | $3.04M 10-Q · filed 2012-05-09 | $3.14M derived: sum of 2 quarters · filed 2013-03-12 | $7.49M derived: sum of 3 quarters · filed 2013-03-12 | |||||||||||
| 2010-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $4.44M derived: sum of 2 quarters · filed 2013-03-12 | $4.92M 10-K · filed 2013-03-12 | |||||||||||
| 2010-09-30 | $4.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $4.82M 10-Q · filed 2011-11-08 | ||||||||||||
| 2010-06-30 | $478.00K 10-Q · filed 2011-08-11 | |||||||||||||
| 2009-12-31 | $13.91M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |